Subscribe to the Big Muddy River Newsletter
Tags
- Abuse
- Addiction
- ADHD
- alternatives
- Anti-anxiety
- antidepressant
- antipsychotic
- Brain
- CCHR
- Child Drugging
- Coercive psychiatry
- Cures
- Depression
- DSM
- ECT
- Elderly Abuse
- FDA
- Foster Children
- Fraud
- Human Rights
- Informed Consent
- Involuntary Commitment
- justice
- Living Will
- Marijuana
- Medicaid
- Mental Health
- Military
- Misdiagnosis
- Missouri
- Psychiatric Drugs
- psychology
- PTSD
- Racism
- restraints
- Schizophrenia
- Schools
- Screening
- Side Effects
- suicide
- TakeAction
- United Nations
- UN SDG
- violence
- Withdrawal
Meta
Pages
- “Sandbag the psychs” Briefing 8/16/2008 Photo Gallery
- About
- Big Muddy River News & Press Releases Index
- Halloween 2007 Photo Gallery
- January 2010 Briefing Photo Gallery
- Making A Killing – DVD Documentary Survey
- Marketing of Madness – DVD documentary survey
- Mental Health Day 10 Oct 2008 Photo Gallery
- Mental Health Day 10/10/2007 Photo Gallery
- Psychiatry Kills Exhibit 2/23/04 Photo Gallery
- Psychiatry: An Industry of Death Touring Exhibit February 2010 Photo Gallery
- Psychiatry: An Industry of Death Touring Exhibit February 2011 Photo Gallery
- Psychiatry: An Industry of Death Touring Exhibit February 2012 Photo Gallery
- Psychiatry: An Industry of Death Touring Exhibit January 2008 Photo Gallery
- Psychiatry: An Industry of Death Touring Exhibit January 2009 Photo Gallery
- Take Back Our Community 2/4/06 Photo Gallery
Other CCHR Links
Return to CCHR STL Home Page
Blog Stats
- 63,197 hits
Tag Archives: MDMA
CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress
Committee’s recommendation to reject as therapy the psychedelic drug MDMA, also known as the “date rape” drug Ecstasy, comes after evidence from clinical trials was deemed insufficient to establish safety or effectiveness. Continue reading
Posted in Big Muddy River Newsletter, Press Releases Tagged antidepressant, FDA, MDMA, psychedelics, PTSD, Side Effects Comments Off on CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress